The World Health Organization declared monkeypox a global emergency July 23, and the U.S. issued a similar declaration Aug. 4. More than 14,000 cases have been confirmed in the U.S. as of Aug. 18, according to CDC data.

Quest Diagnostics launched an obstetrics test panel for screening pregnant people for hepatitis C.

Richardson, Texas-based management and automation services lab OneSmartLaboratory is partnering with cybersecurity firm Intrusion, Inc., to protect the lab's client operations and connectivity.

Molecular diagnostics company Qiagen launched the first syndromic test that differentiates between monkeypox and five other viruses with similar symptoms.

Raleigh, N.C.-based national reference lab Mako Medical Laboratories was accredited as an American Society of Phlebotomy Technicians training school.

Labcorp is partnering with BD to develop flow cytometry-based companion diagnostics for diseases including cancer.

Chinese manufacturer Haimen Shengbang Laboratory Equipment recalled 4.1 million viral transport media containers and swabs, the FDA said Aug. 9.

Lansing, Mich.-based Sparrow Health is using a new in-house system at its lab in Lansing to test for monkeypox, the Detroit Free Press reported Aug. 8.

Medical technology company Becton, Dickinson and Co. is partnering with life sciences company Labcorp to develop cytometry-based companion diagnostics that can be used to match patients with treatments.

Provista Diagnostics, a lab owned by diagnostics company Todos Medical, is entering into two contracts for PCR monkeypox testing.

Technicians at Quest Diagnostics and Labcorp have been refusing to draw blood from people who might have monkeypox, CNN reported Aug. 4.

North American Diagnostics recalled a series of oral COVID-19 rapid antigen test kits, the FDA said Aug. 1.

Removing a race modifier from a standard kidney disease diagnosis formula could reduce healthcare disparities, according to a study from researchers at the University of Texas Southwestern Medical Center and Parkland Health, both based in Dallas.

The COVID-19 pandemic introduced a shortage of blue top blood test tubes, and the experience could reduce wasteful testing even after supply chain issues are rectified.

As at-home COVID-19 tests rise in popularity, U.S. laboratories are slimming their workforce and decreasing their capacity for processing PCR tests, The Wall Street Journal reported July 24. 

Quest Diagnostics released its financial results for the second quarter of 2022. Five things to know:

Thirty-six people are being charged for alleged medical fraud totaling more than $1.2 billion, the Justice Department said July 20.

Rite Aid and Quest Diagnostics are partnering to bolster PCR test offerings for COVID-19.

COVID-19 testing and national reference lab Mako Medical Laboratories is buying four liquid handling automation systems to expand its testing capacity.

Independent diagnostics firm Neelyx Labs is now processing monkeypox PCR tests.